Suppr超能文献

在接受皮质类固醇治疗的患者中,I 期特发性膜性肾病中肾小球毛细血管 C3d 持续存在,但 IgG 沉积不存在。

The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment.

机构信息

Department of Pathology, Dongfang Hospital, Fujian Medical University, Fuzhou 350025, China.

出版信息

Diagn Pathol. 2012 Aug 21;7:109. doi: 10.1186/1746-1596-7-109.

Abstract

BACKGROUND

Pathologic diagnosis of stage I idiopathic membranous nephropathy (MN-I) requires electron microscopy or immunohistochemistry that shows a glomerular capillary staining pattern of IgG and C3. However, it is not uncommon that renal biopsy did not obtain sufficient material for electron microscopy and that IgG and C3 staining in glomeruli largely lost at biopsy due to corticosteroid treatment. Since C3d is one of the final degradation products of C3 that is more stable in vivo, we determine if C3d staining could be used as a novel immunohistochemical marker for MN-I.

METHODS AND RESULTS

74 MN-I patients with electron microscopy proven MN-I were examined by immunoperoxidase staining of C3d. Intensive C3d staining was present in glomerular capillary like the staining pattern of IgG and C3 in MN-I. Importantly, in 40 MN-I patients who underwent corticosteroid treatment at biopsy the intensity and glomerular capillary pattern of C3d staining remained largely intact while the staining for IgG had substantially reduced and the pattern of glomerular capillary staining became unrecognizable.

CONCLUSIONS

C3d glomerular capillary staining may be a novel marker for pathologic diagnosis of MN-I that is continuously present at biopsy in patient who has received corticosteroid treatment.

VIRTUAL SLIDES

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2120780075734479.

摘要

背景

特发性膜性肾病(MN-I)的病理诊断需要电子显微镜或免疫组织化学检查,显示肾小球毛细血管 IgG 和 C3 的染色模式。然而,肾脏活检通常无法获得足够的电子显微镜材料,并且由于皮质类固醇治疗,活检时肾小球中的 IgG 和 C3 染色大部分丢失并不罕见。由于 C3d 是 C3 的最终降解产物之一,在体内更稳定,因此我们确定 C3d 染色是否可作为 MN-I 的新型免疫组织化学标志物。

方法和结果

通过免疫过氧化物酶染色 C3d 检查了 74 例经电子显微镜证实为 MN-I 的 MN-I 患者。在 MN-I 中,C3d 在肾小球毛细血管中呈现出与 IgG 和 C3 染色模式相似的强烈染色。重要的是,在 40 例在活检时接受皮质类固醇治疗的 MN-I 患者中,C3d 染色的强度和肾小球毛细血管模式基本保持完整,而 IgG 的染色则大大减少,肾小球毛细血管染色的模式变得难以识别。

结论

C3d 肾小球毛细血管染色可能是 MN-I 病理诊断的一种新型标志物,在接受皮质类固醇治疗的患者的活检中持续存在。

幻灯片

本文的虚拟幻灯片可在此处找到:http://www.diagnosticpathology.diagnomx.eu/vs/2120780075734479.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbd/3487902/44387739c539/1746-1596-7-109-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验